Sign In
Buy MYO
$1.10
+0.0400 (+3.77%)
At Close: Jun 03, 2026
Myomo (MYO) Projected to Post Quarterly Earnings on Monday
02:30am, Monday, 02'nd Mar 2026
Myomo (NYSEAMERICAN:MYO - Get Free Report) will likely be announcing its Q4 2025 results before the market opens on Monday, March 9th. Analysts expect Myomo to post earnings of ($0.09) per share and r
Myomo, Inc. (MYO) Q3 2025 Earnings Call Transcript
10:41pm, Monday, 10'th Nov 2025
Myomo, Inc. ( MYO ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Paul Gudonis - President, CEO & Chairman David Henry - Chief Financial Officer Conference Call Participants
Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates
07:56pm, Monday, 10'th Nov 2025
Myomo, Inc. (MYO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.03 per share a year ago.
Myomo Reports Third Quarter 2025 Financial and Operating Results
04:05pm, Monday, 10'th Nov 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo (MYO) to Release Quarterly Earnings on Wednesday
03:02am, Tuesday, 04'th Nov 2025
Myomo (NYSEAMERICAN:MYO - Get Free Report) is projected to announce its Q3 2025 results before the market opens on Wednesday, November 5th. Analysts expect Myomo to post earnings of ($0.11) per share
Myomo to Report Third Quarter 2025 Financial Results on November 10
04:05pm, Monday, 03'rd Nov 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference
04:05pm, Tuesday, 02'nd Sep 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
08:01pm, Monday, 11'th Aug 2025
Myomo, Inc. (MYO) came out with a quarterly loss of $0.11 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.03 per share a year ago.
Myomo, Inc. (MYO) Q2 2025 Earnings Conference Call Transcript
06:56pm, Monday, 11'th Aug 2025
Myomo, Inc. (NYSE:MYO ) Q2 2025 Earnings Conference August 11, 2025 4:30 PM ET Company Participants David A. Henry - Chief Financial Officer Paul R.
Myomo Reports Second Quarter 2025 Financial and Operating Results
04:05pm, Monday, 11'th Aug 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo to Report Second Quarter 2025 Financial Results on August 11
04:05pm, Monday, 04'th Aug 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo, Inc.(NYSEAM:MYO) added to Russell 3000 Growth Index
03:16pm, Monday, 30'th Jun 2025
Myomo, Inc.(NYSEAM:MYO) added to Russell 3000 Growth Index
Myomo Provides Highlights of Today's Investor & Analyst Day Event
08:30am, Wednesday, 18'th Jun 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
11,499 Shares in Myomo, Inc. (NYSEAMERICAN:MYO) Acquired by Squarepoint Ops LLC
03:34am, Wednesday, 11'th Jun 2025
Squarepoint Ops LLC purchased a new position in shares of Myomo, Inc. (NYSEAMERICAN:MYO – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with
Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript
09:00pm, Wednesday, 07'th May 2025
Myomo, Inc. (NYSE:MYO ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, Investor Relations Paul Gudonis - Chief Executive Officer Dave Hen
